Navigation Links
PDI Announces Group DCA's Launch of eDetailing Across Apple® and Android™ Mobile Devices
Date:4/25/2011

PARSIPPANY, N.J., April 25, 2011 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Group DCA has expanded its proprietary DIAGRAM™ software platform to enable eDetail delivery on popular mobile devices including the iPad®, iPod touch® and iPhone®(1) and Android™(2)-based phones.

"With physicians adopting smartphones and other mobile devices even faster than the general population, we are moving quickly to meet their information demands across all key media," said Jo Ann Saitta, SVP of Information Technology for PDI. "This extension of eDetailing to mobile programs is consistent with our growth strategy and positions PDI and Group DCA well across a broad range of communications channels to deliver our clients' messages to healthcare professionals."

Noted Ron Scalici, Group DCA Chief Innovations Officer, "Not only can our clients now reach physicians via multiple devices, but they can be assured that our content will be innovative and tailored specifically to particular platforms, while remaining confident in our commitment to complying with the requirements and appropriate disclosure standards of The Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA)."

Group DCA's eDetailing programs utilize its proprietary DIAGRAM™ software to create a customized, self-initiated experience for each participant based upon their attitudes, preferences and information needs. An integrated data warehouse and centralized content library allow for greater efficiency in content creation and dissemination, and easy adaption of approved marketing materials across multiple device platforms. These capabilities facilitate the development and execution of additional outreach efforts under a broader, multi-channel strategy that may include PDI's field sales representatives, teledetailing, email and direct marketing.

About PDI, Inc.

PDI, with its interactive digital agency Group DCA, is a leading provider of integrated multi-channel promotional outsource services to established and emerging health care companies. The company is dedicated to enhancing engagement with healthcare practitioners and optimizing commercial investments for its clients by providing strategic flexibility, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com.

(1) Apple, iPad, iPod touch and iPhone are registered trademarks of Apple Inc.

(2) Android is a trademark of Google Inc.

www.pdi-inc.com


'/>"/>
SOURCE PDI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
2. iMD Companies, Inc. Announces Expansion of OMI Operations
3. Jazz Pharmaceuticals Announces First Quarter 2011 Results Conference Call on May 3
4. Important Drug Product Notice: Luitpold Pharmaceuticals, Inc. Announces Temporary Suspension of Distribution and Manufacture of Drug Products
5. Misonix Announces New Distribution Agreement for Colombia
6. Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast
7. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
8. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
9. China Shenghuo Announces New Chief Financial Officer
10. ULURU Inc. Announces Going Concern Qualification
11. Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... , January 16, 2017 Der ... Kollagenprodukten für die Regeneration des menschlichen Gewebes, gibt die ... mit sofortiger Wirkung bekannt. ... Bill Allan ... Er bekleidete eine Reihe von Geschäftsführer- und anderen Führungspositionen ...
(Date:1/13/2017)... Eli Lilly and Company (NYSE: ... ) announced today that the U.S. Food and Drug ... new drug application (NDA) for investigational baricitinib, a once-daily ... rheumatoid arthritis (RA). The NDA for baricitinib was submitted ... FDA extended the action date to allow time to ...
(Date:1/13/2017)... , Jan. 13, 2017 Wichita Laser ... cutting-edge laser treatments to Wichita, Kansas ... provides advanced treatments for skin rejuvenation, getting rid of ... lesions and vascular lesions. "Since being in ... in Wichita for laser tattoo ...
Breaking Medicine Technology:
(Date:1/13/2017)... ... 13, 2017 , ... People with type 2 diabetes know ... easy as checking the nutrition label on foods for grams of sugar. But ... sugar-free, proteins can influence — either positively or negatively — insulin secretion and ...
(Date:1/13/2017)... ... January 13, 2017 , ... A January 10 article ... 2017 according to the publication, with an emphasis on some new techniques that the ... F.A.C.S., who is known more casually to his patients and colleagues as Dr. J, ...
(Date:1/13/2017)... ... , ... With the increasing public preference for chemical-free personal ... alternatives for customers who have grown more conscious about maintaining their health and ... charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained their company’s decision ...
(Date:1/13/2017)... ... 2017 , ... An inventor from Virginia Beach, Va., is always on the ... diversify my outfits, so he decided to design something that enhances the look of ... of a belt to allow for quick, easy changing of its look. This not ...
(Date:1/13/2017)... ... , ... "We wanted to create a design for orthodontic appliances that would ... Virginia Beach, Va. , They created a prototype for the patent-pending BRACE FACERS to ... to be customized to suit personal tastes. They can be used to create custom ...
Breaking Medicine News(10 mins):